BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26467658)

  • 1. Multipotent luminal mammary cancer stem cells model tumor heterogeneity.
    Bao L; Cardiff RD; Steinbach P; Messer KS; Ellies LG
    Breast Cancer Res; 2015 Oct; 17(1):137. PubMed ID: 26467658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
    Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
    Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stemness in Wnt-driven mammary tumorigenesis.
    Monteiro J; Gaspar C; Richer W; Franken PF; Sacchetti A; Joosten R; Idali A; Brandao J; Decraene C; Fodde R
    Carcinogenesis; 2014 Jan; 35(1):2-13. PubMed ID: 23955540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
    Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression.
    Cantrell MA; Ebelt ND; Pfefferle AD; Perou CM; Van Den Berg CL
    Oncotarget; 2015 May; 6(14):11863-81. PubMed ID: 25970777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
    Wu J; Crowe DL
    Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer.
    Steenbrugge J; Breyne K; Denies S; Dekimpe M; Demeyere K; De Wever O; Vermeulen P; Van Laere S; Sanders NN; Meyer E
    J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):113-122. PubMed ID: 27714576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
    Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
    Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
    Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
    Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminal progenitors restrict their lineage potential during mammary gland development.
    Rodilla V; Dasti A; Huyghe M; Lafkas D; Laurent C; Reyal F; Fre S
    PLoS Biol; 2015 Feb; 13(2):e1002069. PubMed ID: 25688859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model for luminal epithelial like ER positive subtype of human breast cancer.
    Kumar MJ; Ponvijay KS; Nandhini R; Nagarajan RS; Jose J; Srinivas G; Nagarajan P; Venkatesan R; Kumar K; Singh S
    BMC Cancer; 2007 Sep; 7():180. PubMed ID: 17880731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.
    Moumen M; Chiche A; Decraene C; Petit V; Gandarillas A; Deugnier MA; Glukhova MA; Faraldo MM
    Mol Cancer; 2013 Oct; 12(1):132. PubMed ID: 24171719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
    Ling H; Sylvestre JR; Jolicoeur P
    Oncogene; 2010 Aug; 29(32):4543-54. PubMed ID: 20562911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity.
    Abou-Kheir W; Hynes PG; Martin P; Yin JJ; Liu YN; Seng V; Lake R; Spurrier J; Kelly K
    PLoS One; 2011; 6(10):e26112. PubMed ID: 22022528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteotypic classification of spontaneous and transgenic mammary neoplasms.
    Mikaelian I; Blades N; Churchill GA; Fancher K; Knowles BB; Eppig JT; Sundberg JP
    Breast Cancer Res; 2004; 6(6):R668-79. PubMed ID: 15535849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
    Kim J; Villadsen R; Sørlie T; Fogh L; Grønlund SZ; Fridriksdottir AJ; Kuhn I; Rank F; Wielenga VT; Solvang H; Edwards PA; Børresen-Dale AL; Rønnov-Jessen L; Bissell MJ; Petersen OW
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6124-9. PubMed ID: 22454501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
    Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis.
    Shin DH; Park JH; Lee JY; Won HY; Jang KS; Min KW; Jang SH; Woo JK; Oh SH; Kong G
    Oncotarget; 2015 Jul; 6(19):17276-90. PubMed ID: 25938540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.